市场调查报告书
商品编码
1494612
输液袋市场:按解决方案类型、材料、产能、技术、应用、最终用户 - 2024-2030 年全球预测Infusion Bags Market by Type of Solution (Antibiotics, Chemotherapy Solutions, Intravenous (IV) Fluids), Material (Polyethylene, Polypropylene, Polyvinyl Chloride), Capacity, Technology, Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年输液袋市场规模为52.7亿美元,预计2024年将达56.2亿美元,2030年将达到83.9亿美元,复合年增长率为6.86%。
输液 (IV) 袋包括用于向患者静脉注射液体、药物和营养物质的柔性无菌容器。这些袋子由 PVC、聚烯和其他生物相容性塑胶等材料製成,具有破损风险低、易于运输和储存等优点。市场分析的范围包括对各种袋类型的研究,例如单室、多室以及从小到大不同容量的其他袋类型。它也针对医院、诊所、居家医疗机构和门诊手术中心等部门。由于全球慢性疾病的增加,对静脉输液 (IV) 袋的需求不断增加。不断完善的医疗基础设施导致人们越来越偏好一次性输液产品,而一次性输液产品构成了输液袋的基础。家庭医疗保健服务的日益普及进一步刺激了市场成长。与输液治疗相关的污染和感染风险阻碍了市场成长。
主要市场统计 | |
---|---|
基准年[2023] | 52.7亿美元 |
预测年份 [2024] | 56.2亿美元 |
预测年份 [2030] | 83.9亿美元 |
复合年增长率(%) | 6.86% |
输液治疗技术的不断进步以及环保和生物分解性输液袋的市场开拓预计将为市场成长创造机会。整合安全功能和即时监控的智慧输液系统的不断进步预计将扩大市场成长。
区域洞察
在美洲,对高品质医疗保健服务的需求不断增加,输液袋市场也不断扩大。在美洲,慢性病盛行率的增加和强大的医疗基础设施正在推动输液袋市场的成长。先进技术和医疗保健领域的大量投资正在推动创新输液袋产品的发展。高度的消费者意识和严格的 FDA 法规确保我们的产品符合安全性和有效性标准。在南美洲,发达的公共卫生保健系统和人口老化导致输液袋的需求增加。欧盟 (EU) 国家拥有完善且严格监管的医疗保健产业。不断增长的老年人口和以患者为中心的医疗保健政策正在推动该地区对输液袋的需求。由于环保意识的增强和欧盟严格的医疗设备法规,欧盟消费者对环保、高品质的医疗设备表现出强烈的需求。研究和开发方面的投资促使一些公司开发了生物分解性的输液袋并获得了专利。欧盟市场注重永续性和病人安全,正在采用先进的给药系统和智慧输液技术。随着医疗基础设施投资的增加,中东和非洲输液袋市场正在兴起,特别是在波湾合作理事会(GCC)国家。亚太地区的输液袋市场充满活力且快速成长,以中国、日本和印度为主导。亚太地区人口众多,政府改善医疗服务的努力正在增加对输液袋的需求。
FPNV定位矩阵
FPNV 定位矩阵对于评估输液袋市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对输液袋市场供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对输液袋市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[198 Pages Report] The Infusion Bags Market size was estimated at USD 5.27 billion in 2023 and expected to reach USD 5.62 billion in 2024, at a CAGR 6.86% to reach USD 8.39 billion by 2030.
Infusion (IV) bags encompass flexible, sterile containers used for the intravenous administration of fluids, medications, and nutritional substances to patients. These bags are made from materials such as PVC, polyolefin, and other biocompatible plastics, offering advantages such as lower risk of breakage and ease of transportation and storage. The scope of the market analysis includes an examination of various bag types, such as single-chamber, multi-chamber, and others, for different volumes ranging from small to large capacity. It covers sectors such as hospitals, clinics, home care settings, and ambulatory surgical centers. The rise in chronic diseases worldwide expands the need for Infusion (IV) bags. The increasing preference for single-use, disposable infusion products with constant improvements in healthcare infrastructure is creating a platform for infusion bags. The growing adoption of home healthcare services further stimulates market growth. The risk of contamination and infection associated with infusion therapies hampers the market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.27 billion |
Estimated Year [2024] | USD 5.62 billion |
Forecast Year [2030] | USD 8.39 billion |
CAGR (%) | 6.86% |
Continuous technological advancements in infusion therapies and the development of eco-friendly, biodegradable infusion bags are anticipated to create opportunities for market growth. Rising advancements in smart infusion systems integrated with safety features and real-time monitoring are expected to expand the market growth.
Regional Insights
In the Americas, the growing need for quality healthcare services extends to the market for infusion bags. In the Americas, the increasing prevalence of chronic diseases coupled with a strong healthcare infrastructure propels the growth of the infusion bags market. Advanced technologies and significant investments in the healthcare sector facilitate the development of innovative infusion bag products. High levels of consumer awareness and strict FDA regulations ensure that products meet safety and efficacy standards. In South America, a robust public healthcare system and an increasingly aging population contribute to the rise in demand for infusion bags. European Union (EU) countries have a well-established and heavily regulated healthcare sector. The increase in the geriatric population and patient-centric healthcare policies drive the demand for infusion bags in this region. EU consumers exhibit a high need for eco-friendly and high-quality medical devices due to heightened environmental awareness and stringent EU medical device regulations. Investment in research has led to the development of biodegradable infusion bags, with some companies obtaining patents for the same. With a focus on sustainability and patient safety, the EU market is receptive to advanced drug delivery systems and smart infusion technologies. The market for infusion bags in the Middle East and Africa is emerging with increased investments in healthcare infrastructure, particularly in the Gulf Cooperation Council (GCC) countries. The Asia-Pacific region exhibits a dynamic and rapidly growing market for infusion bags, with countries including China, Japan, and India at the forefront. Asia-Pacific's large population base and government initiatives to improve healthcare services have led to an increased demand for infusion bags.
Market Insights
The market dynamics represent an ever-changing landscape of the Infusion Bags Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infusion Bags Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infusion Bags Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Amneal Launched 39 New Retail and Injectable Products in 2023
Amneal Pharmaceuticals, Inc. significantly expanded its product catalog with the introduction of 39 new medicines in 2023. Amneal debuted 13 products, of which five are injectables, augmenting its presence in the infusion bag market. [Published On: 2024-01-04]
Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals
Baxter International Inc. announced the successful completion of the inaugural phase of its innovative IV bag recycling initiative. In partnership with Northwestern Medicine, the pioneering pilot program has effectively diverted over six tons of polyvinyl chloride (PVC) IV bag waste from landfills, advocating for environmental responsibility in the medical sector. [Published On: 2023-12-13]
Local Infusion Raises USD 10 Million in Series A Funding
Local Infusion, an innovative Nashville-based provider of tech-enabled infusion bag services, secured USD 10M in a Series A funding round guided by Blisce, with Meridian Street Capital and current investors contributing as well. This substantial investment will fuel the company's strategic growth plans, including opening 16 new centers across four states in the Northeastern United States. [Published On: 2023-11-30]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infusion Bags Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Infusion Bags Market, highlighting leading vendors and their innovative profiles. These include Alfa Laboratories, APG Europe, B. Braun SE, Baxter international Inc., Becton, Dickinson and Company, Biometrix Corporation, CellBios Healthcare & Lifesciences Pvt. Ltd., Fairmont Medica, Fresenius Kabi, Hospira by Pfizer Inc., ICU Medical Inc., Kraton Corporation, LyondellBasell Industries Holdings B.V., Medicopack A/S, Mitra Industries Private Limited, Nipro Corporation, Otsuka Pharmaceutical Co., Ltd., Poly Medicure Ltd., Polycine GmbH, Qosina Corporation, RAUMEDIC AG, RENOLIT SE, Simulab Corporation, Technoflex S.A, Terumo Corporation, The Dow Chemical Company, The Metrix Company, and Unimedix Medical Equipments LLP.
Market Segmentation & Coverage
TA